A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Clinical trial NCT03353454 · WITHDRAWN
Trial details
- NCT number
- NCT03353454
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-25
- Primary completion
- 2020-06-15
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.